Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$14.6B
sum of reported positions
Reported positions
522
Changes vs prior quarter
505
102 new · 66 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 161 measured positions in 8 quarters, the typical new or larger position finished −2.3 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | 42.9M | $1.45B | 9.9% |
| 3.51M | $914M | 6.2% | |
SELECT SECTOR SPDR TR | 4.23M | $784M | 5.4% |
ISHARES TR | 4.01M | $579M | 4.0% |
| 1.16M | $553M | 3.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.5B | $14.6B |
| Positions | 486 | 522 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 10% |
INVESCO EXCHANGE TRADED FD T |
| 2.31M |
| $491M |
| 3.4% |
| 2.31M | $461M | 3.2% |
| 1.46M | $349M | 2.4% |
| 618K | $335M | 2.3% |
VANGUARD SCOTTSDALE FDS | 3.04M | $323M | 2.2% |
ISHARES TR | 1.28M | $310M | 2.1% |
| 862K | $305M | 2.1% |
| 390K | $297M | 2.0% |
| 795K | $296M | 2.0% |
ISHARES TR | 2.68M | $264M | 1.8% |
| 751K | $256M | 1.7% |
| 646K | $244M | 1.7% |
ISHARES TR | 1.51M | $237M | 1.6% |
| 695K | $201M | 1.4% |
| 808K | $198M | 1.4% |
| 1.37M | $196M | 1.3% |
| 2.08M | $190M | 1.3% |
SELECT SECTOR SPDR TR | 988K | $188M | 1.3% |
| 5.37M | $187M | 1.3% |
ISHARES INC | 4.99M | $172M | 1.2% |
Onto Innovation (ONTO)
402K shares
ISHARES TR
4.99M shares
SELECT SECTOR SPDR TR
687K → 2.93M shares (+327%)
Vistra Corp. (VST)
10K → 784K shares (+7545%)
STATE STR SPDR S&P 500 ETF T
92K → 165K shares (+79%)
ISHARES TR
1.3M → 1.31M shares (+2%)
Eli Lilly (LLY)
101K → 97K shares (−4%)
Alphabet (GOOGL)
244K → 307K shares (+26%)
Globalfoundries (GFS)
1.1M → 1.31M shares (+19%)
Wells Fargo (WFC)
987K → 1.31M shares (+33%)
LISTED FDS TR
1.63M shares
Enlight Renewable Energy (ENLT)
1.25M → 1.14M shares (−9%)
Forgent Power Solutions (FPS)
1.66M shares
SELECT SECTOR SPDR TR
2.3M → 1.7M shares (−26%)
Cellebrite Di (CLBT)
4.18M → 6.18M shares (+48%)
Boston Scientific (BSX)
1.55M → 1.96M shares (+27%)
SELECT SECTOR SPDR TR
1.53M → 1.51M shares (−1%)
Icl Group (ICL)
15.3M → 15.6M shares (+2%)
SPROTT FDS TR
1.25M shares
ISHARES TR
2.82M → 1.28M shares (−55%)
Nice (NICE)
284K → 678K shares (+139%)
SPDR SERIES TRUST
1.26M → 691K shares (−45%)
Ormat Technologies (ORA)
106K → 554K shares (+424%)
ISHARES TR
1.91M → 1.09M shares (−43%)
Firefly Aerospace (FLY)
660K → 1.81M shares (+175%)